Benzyl Lysine Eye Drops

This product is an aldose reductase (AR) inhibitor. Literature reports show that it has an inhibitory effect on lens aldose reductase (AR). Therefore, benzyl dazine (BDZL) eye drops are used to inhibit the activity of AR in the eye to achieve the purpose of preventing or treating cataracts.

Each bottle of this product contains 25 mg of benzyl lysine. The excipients are hypromellose, sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium chloride, and thimerosal (mercury compound, 0.001%).

This product is a colorless or almost colorless clear liquid

Early senile cataract

Eye drops, 3 times a day, 1 to 2 drops each time or as directed by your doctor.

There may be transient burning sensation, tearing and other reactions, but they can be adapted to as the medication time is extended. Rarely, there may be difficulty in swallowing, nausea, vomiting, diarrhea, tearing, contact dermatitis, etc.

Do not use in case of eye injury or severe infection, or follow doctor's advice

Precautions for children: Not yet determined. Precautions for pregnancy and lactation: Not yet determined. Precautions for the elderly: Not yet determined.

If used with other drugs, drug interactions may occur. Please consult your doctor or pharmacist for details.

Keep away from light and store in airtight container.

5 ml: 25 mg

36 months

Zhejiang Shapuaisi Pharmaceutical Co., Ltd.

• Founded in:

  2000-07-17

• Address:

  No. 1588, Xinming Road, Economic Development Zone, Pinghu City, Zhejiang Province

• Tax NO.:

  91330000146644116H

• Registered Funds:

  375.925005 yuan

• Website:

  Log in to view

• Email:

  Log in to view